PRINCETON, N.J. & ALAMEDA, Calif.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) and Exelixis, Inc. (NASDAQ: EXEL) today announced that the U.S. Food and Drug Administration...
SAN DIEGO--(BUSINESS WIRE)--VelosBio Inc. (VelosBio), a clinical-stage biopharmaceutical company committed to developing first-in-class cancer therapies targeting receptor tyrosine kinase-like orphan receptor 1 (ROR1), today...
PHOENIX--(BUSINESS WIRE)--OncoMyx Therapeutics, a privately-held viral immunotherapy company, announced the presentation of preclinical data at the AACR Virtual Special Conference: Tumor Immunology and Immunotherapy...
SANTA MONICA, Calif.--(BUSINESS WIRE)--DRE is pleased to welcome four new members to its MSAB. They join Chair, Ameet Nathwani, MD, MRCP, DipPharmMed, MBA in...
PHILADELPHIA--(BUSINESS WIRE)--TransCelerate Biopharma Inc. (TransCelerate) announced today that it has launched a number of new initiatives to improve the research and development of medicines....
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, and Hangzhou Zhongmei...
WASHINGTON--(BUSINESS WIRE)--The College of American Pathologists (CAP) strongly objected to Medicare cuts to fees for certain COVID-19 tests, which the Centers for Medicare &...
